Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Chronic kidney disease
•
Nephrology
Do you recommend delaying spot urine protein quantification testing until after nephrostomy tube removal in a patient with obstructive uropathy?
Answer from: at Community Practice
Yes, if the tubes are coming out. Would not want to make treatment decisions under these circumstances. Not an emergency usually.
Sign in or Register to read more
Answer from: at Academic Institution
Not necessarily. I don't think it would affect it much.
Sign in or Register to read more
26903
26910
Related Questions
Do you prefer celecoxib over a nonselective NSAID in patients with chronic kidney disease?
Do you rule out active urinary tract infections prior to performing a kidney biopsy?
Do you recommend dietary protein restriction in your patients with chronic kidney disease?
Would you avoid SGLT2 inhibitors in patients with nephrostomy tubes?
Do you recommend hydrochlorothiazide to manage polyuria in patients with ADPKD who are on tolvaptan?
Do you prefer to simultaneously start an ACEi/ARB and SGLT2i or initiate one prior to the other in a patient with proteinuria secondary to diabetic kidney disease?
Is your decision to prescribe empagliflozin for CKD patients without albuminuria influenced by a recent cost-utility analysis showing that empagliflozin was not cost-effective for this group?
What are some indications that might lead you to pursue a kidney biopsy in a patient with presumed diabetic kidney disease?
What is your approach to managing constipation in patients with chronic kidney disease?
Do you offer home administration of ESAs for your patients with anemia of chronic kidney disease?